INSM1 and pituitary gland adenoma: Although its mRNA levels are significantly reduced in healthy adult tissues, INSM1 is expressed in various neuroendocrine tumours such as insulinomas, pituitary adenomas and medullary thyroid carcinomas, and it is also a specific marker for SCLC [10,19,20,21].